Myocardial BDNF regulates cardiac bioenergetics through the transcription factor Yin Yang 1

Serum Brain-derived Neurotrophic Factor (BDNF) is markedly decreased in heart failure patients. Both BDNF and its receptor, Tropomyosin Related Kinase Receptor (TrkB), are expressed in cardiomyocytes, however the role of myocardial BDNF signaling in cardiac pathophysiology is poorly understood. We found that myocardial BDNF expression was increased in mice with swimming exercise, but decreased in a mouse heart failure model. Cardiac-specific TrkB knockout (cTrkB KO) mice displayed a blunted adaptive cardiac response to exercise, with attenuated upregulation of transcription factor networks controlling mitochondrial biogenesis/metabolism, including Peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α). In response to pathological stress (transaortic constriction, TAC), cTrkB KO mice showed an exacerbated heart failure progression. The expression of PGC-1α and other metabolic transcription factors were downregulated in cTrkB KO mice exposed to TAC. Consistent with this, mitochondrial DNA copy number and mitochondrial protein abundance was markedly decreased in cTrkB KO mice, resulting in decreased mitochondrial respiratory function. We further unraveled that BDNF induces PGC-1α upregulation and bioenergetics through a novel signaling pathway, the pleiotropic transcription factor Yin Yang 1 (YY1). Taken together, our findings suggest that myocardial BDNF plays a critical role in regulating cellular energetics in the cardiac stress response.

[1]  H. Völzke,et al.  Brain-derived neurotrophic factor is related with adverse cardiac remodeling and high NTproBNP , 2019, Scientific Reports.

[2]  Matthew C. Hill,et al.  Tet inactivation disrupts YY1 binding and long-range chromatin interactions during embryonic heart development , 2019, Nature Communications.

[3]  E. Castrén,et al.  Antidepressant drugs act by directly binding to TRKB neurotrophin receptors , 2019, Cell.

[4]  P. Bekinschtein,et al.  Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain , 2019, Front. Cell. Neurosci..

[5]  I. Scott,et al.  Loss of GCN5L1 in cardiac cells limits mitochondrial respiratory capacity under hyperglycemic conditions , 2019, Physiological Reports.

[6]  U. Ekelund,et al.  Sitting Time, Physical Activity, and Risk of Mortality in Adults. , 2019, Journal of the American College of Cardiology.

[7]  A. Drilon,et al.  NTRK fusion-positive cancers and TRK inhibitor therapy , 2018, Nature Reviews Clinical Oncology.

[8]  Steven E. Nissen,et al.  Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing , 2018, JAMA network open.

[9]  S. Yusuf,et al.  The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study , 2017, The Lancet.

[10]  Daniel S. Day,et al.  YY1 Is a Structural Regulator of Enhancer-Promoter Loops , 2017, Cell.

[11]  I. Atanassov,et al.  Increased Total mtDNA Copy Number Cures Male Infertility Despite Unaltered mtDNA Mutation Load. , 2017, Cell Metabolism.

[12]  Rick B. Vega,et al.  Molecular Mechanisms Underlying Cardiac Adaptation to Exercise. , 2017, Cell metabolism.

[13]  J. Granger,et al.  Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart. , 2016, Journal of Visualized Experiments.

[14]  L. Wilkins Circulating Brain‐Derived Neurotrophic Factor Concentrations and the Risk of Cardiovascular Disease in the Community , 2016, Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease.

[15]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[16]  O. Kretz,et al.  Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure , 2015, Circulation research.

[17]  L. Cantley,et al.  Regulation of mTORC1 by PI3K signaling. , 2015, Trends in cell biology.

[18]  Y. Izumiya,et al.  Significance of low plasma levels of brain-derived neurotrophic factor in patients with heart failure. , 2015, The American journal of cardiology.

[19]  Rick B. Vega,et al.  Maintaining ancient organelles: mitochondrial biogenesis and maturation. , 2015, Circulation research.

[20]  D. Kass,et al.  Constitutive BDNF/TrkB signaling is required for normal cardiac contraction and relaxation , 2015, Autonomic Neuroscience.

[21]  K. Oba,et al.  Serum Brain-Derived Neurotrophic Factor Level Predicts Adverse 1 Clinical Outcomes in Patients with Heart Failure , 2017 .

[22]  R. Hughes,et al.  TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination , 2014, Molecular and Cellular Neuroscience.

[23]  S. Anker,et al.  Metabolic impairment in heart failure: the myocardial and systemic perspective. , 2014, Journal of the American College of Cardiology.

[24]  M. White,et al.  Insulin Receptor Substrates Are Essential for the Bioenergetic and Hypertrophic Response of the Heart to Exercise Training , 2014, Molecular and Cellular Biology.

[25]  M. Mattson,et al.  BDNF mediates adaptive brain and body responses to energetic challenges , 2014, Trends in Endocrinology & Metabolism.

[26]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[27]  Markus Krane,et al.  Essential and Unexpected Role of Yin Yang 1 to Promote Mesodermal Cardiac Differentiation , 2013, Circulation research.

[28]  D. Ginty,et al.  Sexually Dimorphic BDNF Signaling Directs Sensory Innervation of the Mammary Gland , 2012, Science.

[29]  M. Mattson,et al.  Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines , 2012, Nature Communications.

[30]  S. Cortassa,et al.  GSH or Palmitate Preserves Mitochondrial Energetic/Redox Balance, Preventing Mechanical Dysfunction in Metabolically Challenged Myocytes/Hearts From Type 2 Diabetic Mice , 2012, Diabetes.

[31]  K. Chowdhury,et al.  The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy , 2012, Nature Communications.

[32]  I. Komuro,et al.  Brain-Derived Neurotrophic Factor Protects Against Cardiac Dysfunction After Myocardial Infarction via a Central Nervous System–Mediated Pathway , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[33]  D. Kass,et al.  Pathological Cardiac Hypertrophy Alters Intracellular Targeting of Phosphodiesterase Type 5 From Nitric Oxide Synthase-3 to Natriuretic Peptide Signaling , 2012, Circulation.

[34]  D. Kelly,et al.  The PGC-1 cascade as a therapeutic target for heart failure. , 2011, Journal of molecular and cellular cardiology.

[35]  Iain McDonald,et al.  Thioredoxin Reductase-2 Is Essential for Keeping Low Levels of H2O2 Emission from Isolated Heart Mitochondria* , 2011, The Journal of Biological Chemistry.

[36]  Dong I. Lee,et al.  Myocardial remodeling is controlled by myocyte-targeted gene regulation of phosphodiesterase type 5. , 2010, Journal of the American College of Cardiology.

[37]  M. Bilgen,et al.  Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. , 2010, The Journal of clinical investigation.

[38]  Yang Liu,et al.  A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone , 2010, Proceedings of the National Academy of Sciences.

[39]  M. Febbraio,et al.  Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase , 2009, Diabetologia.

[40]  W. Kraus,et al.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.

[41]  T. McKinsey,et al.  YY1 protects cardiac myocytes from pathologic hypertrophy by interacting with HDAC5. , 2008, Molecular Biology of the Cell.

[42]  R. Roberts Faculty Opinions recommendation of mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. , 2007 .

[43]  Gail Mandel,et al.  Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA , 2007, Nature Neuroscience.

[44]  M. Birnbaum,et al.  A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. , 2007, Cell metabolism.

[45]  B. Bonavida,et al.  Transcription factor YY1: structure, function, and therapeutic implications in cancer biology , 2006, Oncogene.

[46]  G. Dorn,et al.  Protein kinase cascades in the regulation of cardiac hypertrophy. , 2005, The Journal of clinical investigation.

[47]  J. Huss,et al.  Nuclear receptor signaling and cardiac energetics. , 2004, Circulation research.

[48]  M. Piepoli,et al.  Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) , 2004, BMJ : British Medical Journal.

[49]  Daisuke Hattori,et al.  DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation , 2003, Science.

[50]  Chun Li Zhang,et al.  Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy , 2002, Cell.

[51]  Xianlin Han,et al.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.

[52]  S. Rafii,et al.  Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. , 2000, Development.

[53]  R. Belardinelli,et al.  Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. , 1999, Circulation.

[54]  E. Jennings,et al.  DNA binding sites for the transcriptional activator/repressor YY1. , 1995, Nucleic acids research.

[55]  Y. Barde,et al.  Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain. , 1990, The EMBO journal.